New Strategies Against Cutaneous Squamous Cell Carcinoma
NCT02672254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2016-02-03
Summary
The gold treatment for local invasive cutaneous squamous cell carcinoma is surgical excision. Nevertheless, surgery is not always an option as a consequence of the age and/or the health status of the patient. One of the objectives of this study is to assess the effects of cisplatin concomitantly with a subsequent low-energy X-rays irradiation in vitro. In order to enhance the effectiveness of this combined treatment, the temporal fractionation of the platinated compound is expected to be performed.
Conditions
Interventions
- RADIATION
-
Samples with 2 treatments
Study the concomitant effects between chemo- and radiotherapy by means of cellular techniques.
Sponsors & Collaborators
-
Hospital Clinic of Barcelona
collaborator OTHER -
Corporacion Parc Tauli
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
More Related Trials
-
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT05992610 ·Status: RECRUITING ·Phase: NA
-
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00402545 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
NCT03333694 ·Status: TERMINATED ·Phase: PHASE1
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study
NCT03325738 ·Status: COMPLETED
-
Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study
NCT03541252 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
NCT00126555 ·Status: COMPLETED ·Phase: PHASE2
-
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
NCT00158678 ·Status: COMPLETED ·Phase: PHASE3
-
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
NCT00176254 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity
NCT02295540 ·Status: WITHDRAWN ·Phase: NA
-
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00623558 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma
NCT04106362 ·Status: TERMINATED ·Phase: PHASE2
-
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT00401323 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
NCT03370367 ·Status: COMPLETED ·Phase: PHASE3
-
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
NCT00566540 ·Status: TERMINATED ·Phase: PHASE2
-
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
NCT02760667 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT01437449 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer
NCT01645748 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537 ·Status: RECRUITING ·Phase: PHASE2
-
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
NCT01612351 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
NCT00176267 ·Status: COMPLETED ·Phase: PHASE2
-
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer
NCT03067610 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139230 ·Status: COMPLETED ·Phase: PHASE2